[Safety and tolerability of nicotinic acid. Results of the multicenter, open, prospective NAUTILUS study].
Vogt
A
A
Charité - Universitätsmedizin Berlin, Campus-Virchow-Klinikum, Lipidambulanz Augustenburger Platz 1, D-13353 Berlin. Anja.Vogt@Charite.de
Kassner
U
U
Hostalek
U
U
Peiter
A
A
Steinhagen-Thiessen
E
E
D016907:Adverse Drug Reaction Reporting Systems; D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D005858:Germany; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D009525:Niacin / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003692:Delayed-Action Preparations; D009525:Niacin